阿鲁多克斯抑制了多种格拉姆阴性病原体的III型分泌
David R Mark1, Nicky O'Boyle2,3, Kabo R Wale1,4
1School of Infection and Immunity, University of Glasgow, Glasgow G12 8TA, UK.
Open biology
|November 26, 2024
概括
一种抗病毒性化合物Aurodox有效地抑制了多种格拉姆阴性病原体的3型分泌系统 (T3SS). 这项研究揭示了其对抗沙门氏菌和大肠杆菌等细菌引起的感染的潜力.
科学领域:
- 微生物学 微生物学
- 细菌病原体的产生
- 药物发现 药物发现 药物发现
背景情况:
- 由于抗生素耐药性,阴性病原体对健康构成重大挑战.
- 抗病毒性 (AV) 化合物通过向病毒性因子而不是细菌活力来提供一种新的策略.
- 在此之前,Aurodox对大肠杆菌的3型分泌系统 (T3SS) 显示出有前途.
研究的目的:
- 调查 aurodox 对各种格拉姆阴性病原体T3SS 的疗效.
- 为了探索aurodox抗病毒活性的保存机制.
- 评估aurodox作为治疗细菌感染的治疗剂的潜力.
主要方法:
- 使用定量实时聚合酶链反应 (qRT-PCR) 来评估T3SS抑制.
- 采用聚焦成像来观察aurodox对受感染宿主细胞的影响.
- 对用aurodox.治疗的大肠杆菌和S. Typhimurium进行了比较性转录基因分析.
主要成果:
- 奥罗多克斯在沙门氏菌 Typhimurium,Yersinia 伪结核病和Vibrio parahaemolyticus的T3SS上表现出抑制作用.
- 在S. Typhimurium中,Aurodox通过阻断SPI-2 T3SS来保护宿主细胞免受晚期感染.
- 转录组数据显示,在对不同病原体的aurodox反应中,基因表达的变化得到了保存.
结论:
- 阿鲁多克斯通过向其T3SS.通过针对关键的格拉姆阴性病原体,表现出广泛的抗病毒活性.
- 该化合物的作用机制似乎保持不变,这表明了更广泛的治疗应用的潜力.
- 对aurodox机制的进一步研究可以指导开发新的抗感染策略.
相关概念视频
Antimicrobial Proteins
907
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
907
Gene Regulation in Microbial Communities: Quorum Sensing
3
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
3
Adrenergic Receptors: ɑ Subtype
1.4K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.4K
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
910
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
910


